| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Mar 05, 2021 | Mar 08, 2021 | Shaw Christine VP Assay Development | Sell | Genmark Diagnostics, Inc. | GNMK | $18.56 | $5,085 | -0.27% |
| Feb 26, 2021 | Mar 01, 2021 | Shaw Christine VP Assay Development | Sell | Genmark Diagnostics, Inc. | GNMK | $17.03 | $53,662 | -2.98% |
| Feb 23, 2021 | Feb 25, 2021 | Shaw Christine VP Assay Development | Sell | Genmark Diagnostics, Inc. | GNMK | $19.21 | $8,164 | -0.40% |
| Jan 27, 2021 | Jan 29, 2021 | Shaw Christine VP Assay Development | Sell | Genmark Diagnostics, Inc. | GNMK | $14.06 | $1,139 | -0.10% |
| Dec 07, 2020 | Dec 09, 2020 | Shaw Christine VP Assay Development | Sell | Genmark Diagnostics, Inc. | GNMK | $13.97 | $3,828 | -0.34% |
| Nov 24, 2020 | Nov 25, 2020 | Shaw Christine VP Assay Development | Sell | Genmark Diagnostics, Inc. | GNMK | $13.17 | $4,675 | -0.45% |
| Oct 27, 2020 | Oct 29, 2020 | Shaw Christine VP Assay Development | Sell | Genmark Diagnostics, Inc. | GNMK | $11.34 | $771 | -0.09% |
| Sep 08, 2020 | Sep 10, 2020 | Shaw Christine VP Assay Development | Sell | Genmark Diagnostics, Inc. | GNMK | $11.02 | $3,141 | -0.36% |
| Aug 25, 2020 | Aug 26, 2020 | Shaw Christine VP Assay Development | Sell | Genmark Diagnostics, Inc. | GNMK | $14.14 | $5,359 | -0.47% |